Invega Hafyera 50458-0612

Generic: Paliperidone Palmitate

Product NDC

50458-0612

Manufacturer: Janssen Pharmaceuticals, Inc
Dosage Form: Injection, Suspension, Extended Release
Route: Intramuscular
Product Type: Human Prescription Drug
Marketing Start: August 30, 2021
Listing Expires: December 31, 2026
Application: NDA207946

Need to source Invega Hafyera? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Paliperidone Palmitate	1560 mg/5mL

Drug Class

Atypical Antipsychotic [EPC]

Packaging Options(1)

50458-0612-01

1 SYRINGE in 1 CARTON (50458-612-01) / 5 mL in 1 SYRINGE

View →